JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB281305

Anti-SARS-CoV-2 Spike RBD antibody [HL1014] - BSA and Azide free

Be the first to review this product! 리뷰 제출

|

(0 출판물)

Rabbit Recombinant Monoclonal SPIKE antibody. Carrier free. Suitable for ICC, sELISA, I-ELISA and reacts with SARS-CoV-2 samples.

대체 명칭 보기

2, S, Spike glycoprotein, S glycoprotein, E2, Peplomer protein

9 이미지
Immunocytochemistry - Anti-SARS-CoV-2 Spike RBD antibody [HL1014] - BSA and Azide free (AB281305)
  • ICC

Supplier Data

Immunocytochemistry - Anti-SARS-CoV-2 Spike RBD antibody [HL1014] - BSA and Azide free (AB281305)

Mock and transfected HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate were fixed in 4% paraformaldehyde at room temperature for 15 minutes. SARS-CoV-2 (COVID-19) Spike RBD stained (green) by ab281305 at 1/2500 dilution immunocytochemical analysis. Fluoroshield with DAPI (blue).

Sandwich ELISA - Anti-SARS-CoV-2 Spike RBD antibody [HL1014] - BSA and Azide free (AB281305)
  • sELISA

Supplier Data

Sandwich ELISA - Anti-SARS-CoV-2 Spike RBD antibody [HL1014] - BSA and Azide free (AB281305)

Sandwich ELISA detection of non-transfected and SARS-CoV-2 (COVID-19) Spike, MERS-CoV Spike, or SARS-CoV Spike transfected HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell extracts using ab281305 as capture antibody at concentration of 5 μg/mL and HRP-conjugated ab281304 as detection antibody at concentration of 1 μg/mL.

Sandwich ELISA - Anti-SARS-CoV-2 Spike RBD antibody [HL1014] - BSA and Azide free (AB281305)
  • sELISA

Supplier Data

Sandwich ELISA - Anti-SARS-CoV-2 Spike RBD antibody [HL1014] - BSA and Azide free (AB281305)

Sandwich ELISA detection of recombinant SARS-CoV-2 (COVID-19) Spike RBD (N501Y Mutant) protein, His tag (active) using ab281305 as capture antibody at 5 μg/mL and HRP-conjugated ab281304 as detection antibody at concentration of 1 μg/mL.

Sandwich ELISA - Anti-SARS-CoV-2 Spike RBD antibody [HL1014] - BSA and Azide free (AB281305)
  • sELISA

Supplier Data

Sandwich ELISA - Anti-SARS-CoV-2 Spike RBD antibody [HL1014] - BSA and Azide free (AB281305)

Sandwich ELISA detection of recombinant full-length SARS-CoV-2 spike (trimer) protein using ab281305 as capture antibody at concentration of 5 μg/mL and a HRP-conjugated ab281303 as detection antibody at concentration of 1 μg/mL.

Sandwich ELISA - Anti-SARS-CoV-2 Spike RBD antibody [HL1014] - BSA and Azide free (AB281305)
  • sELISA

Supplier Data

Sandwich ELISA - Anti-SARS-CoV-2 Spike RBD antibody [HL1014] - BSA and Azide free (AB281305)

Sandwich ELISA detection of recombinant SARS-CoV-2 (COVID-19) Spike S1 protein, His tag (active) protein using ab281305 as capture antibody at concentration of 5 μg/mL and HRP-conjugated SARS-CoV-2 (COVID-19) Spike RBD antibody as detection antibody at concentration of 1 μg/mL.

Indirect ELISA - Anti-SARS-CoV-2 Spike RBD antibody [HL1014] - BSA and Azide free (AB281305)
  • I-ELISA

Supplier Data

Indirect ELISA - Anti-SARS-CoV-2 Spike RBD antibody [HL1014] - BSA and Azide free (AB281305)

Indirect ELISA analysis performed by coating plate with recombinant full-length SARS-CoV-2 spike (trimer) protein (50 ng). Coated protein probed with ab281305 (160-1.91*10-5 nM). HRP-Rabbit IgG antibody at 1/10000 dilution detected bound primary antibody. EC50 : 28.77 pM.

Sandwich ELISA - Anti-SARS-CoV-2 Spike RBD antibody [HL1014] - BSA and Azide free (AB281305)
  • sELISA

Supplier Data

Sandwich ELISA - Anti-SARS-CoV-2 Spike RBD antibody [HL1014] - BSA and Azide free (AB281305)

Sandwich ELISA detection of recombinant SARS-CoV-2 (COVID-19) Spike S1 protein, His tag (active) protein using ab281305 as capture antibody at concentration of 5 μg/mL and a HRP-conjugated ab281304 as detection antibody at concentration of 1 μg/mL.

Sandwich ELISA - Anti-SARS-CoV-2 Spike RBD antibody [HL1014] - BSA and Azide free (AB281305)
  • sELISA

Supplier Data

Sandwich ELISA - Anti-SARS-CoV-2 Spike RBD antibody [HL1014] - BSA and Azide free (AB281305)

Sandwich ELISA detection of recombinant SARS-CoV-2 (COVID-19) Spike (HexaPro) ECD, His tag using ab281305 as capture antibody at concentration of 5 μg/mL and HRP-conjugated SARS-CoV-2 (COVID-19) Spike RBD antibody as detection antibody at concentration of 1 μg/mL.

Sandwich ELISA - Anti-SARS-CoV-2 Spike RBD antibody [HL1014] - BSA and Azide free (AB281305)
  • sELISA

Supplier Data

Sandwich ELISA - Anti-SARS-CoV-2 Spike RBD antibody [HL1014] - BSA and Azide free (AB281305)

Sandwich ELISA detection of recombinant SARS-CoV-2 (COVID-19) Spike RBD (N501Y Mutant) protein, His tag (active) using ab281305 as capture antibody at concentration of 5 μg/mL and HRP-conjugated SARS-CoV-2 (COVID-19) Spike RBD antibody as detection antibody at concentration of 1 μg/mL.

주요 정보

Host species

Rabbit

Clonality

Monoclonal

Clone number

HL1014

Isotype

IgG

Carrier free

Yes

Reacts with

SARS-CoV-2

Applications

sELISA, I-ELISA, ICC

applications

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICC" : {"fullname" : "Immunocytochemistry", "shortname":"ICC"}, "sELISA" : {"fullname" : "Sandwich ELISA", "shortname":"sELISA"}, "IELISA" : {"fullname" : "Indirect ELISA", "shortname":"I-ELISA"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "SARS-CoV-2": { "ICC-species-checked": "testedAndGuaranteed", "ICC-species-dilution-info": "1/100 - 1/2500", "ICC-species-notes": "<p></p>", "sELISA-species-checked": "testedAndGuaranteed", "sELISA-species-dilution-info": "", "sELISA-species-notes": "<p></p>", "IELISA-species-checked": "testedAndGuaranteed", "IELISA-species-dilution-info": "", "IELISA-species-notes": "<p></p>" } } }

특성 및 보관 정보

제형
Liquid
Purification 테크닉
Affinity purification Protein A
보관 버퍼
pH: 7.4 Constituents: PBS
배송 시 보관 조건
Blue Ice
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
+4°C

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

The SARS-CoV-2 Spike RBD also known commonly as the Receptor Binding Domain of the spike protein plays an important role in viral entry into host cells. This domain has a mass of approximately 21 kDa. It is located on the surface of the virus and facilitates binding to the host cell receptor primarily ACE2 which permits viral entry and replication. The Spike RBD is also a target for neutralizing antibodies which are essential in immune response against the virus. The domain displays various mutations particularly in variants of concern such as Omicron which can affect binding efficiency and immune evasion.
Biological function summary

The SARS-CoV-2 Spike RBD interacts directly with the host ACE2 receptor to mediate entry of the virus into host cells. This interaction is necessary for the virus to fuse with the host cell membrane which allows viral RNA to enter the host cell and begin replication. The Spike protein of which the RBD is a part forms a trimeric complex on the virus surface that is important for host interaction. Variations in the Spike RBD such as mutations like Arg319-Phe541 have significant impacts on the binding affinity to ACE2 and the effectiveness of vaccine-elicited antibodies.

Pathways

The Spike RBD of SARS-CoV-2 is vital in the entry pathway of the virus into the host cell. It is prominently involved in the ACE2-mediated signaling pathway with ACE2 playing the key role as the cellular receptor. This pathway is integral to the pathogenesis of COVID-19. Additionally the presence of the virus in host cells can trigger inflammatory pathways via infection-induced signaling cascades which can lead to exacerbated immune responses.

The SARS-CoV-2 Spike RBD is inherently linked to COVID-19 pathogenesis. Variants such as Omicron have alterations within the RBD that may confer increased transmissibility and resistance to neutralizing antibodies. These mutations can influence disease severity and vaccine effectiveness. The interaction between the Spike RBD and ACE2 receptor underlies the symptomatic manifestations of COVID-19 including respiratory distress and systemic inflammation. The emergence of RBD-targeted therapeutics and vaccines addresses its critical role in infection aiming to block the binding and prevent disease progression.

제품 프로토콜

For this product, it's our understanding that no specific protocols are required. You can visit:

타겟 정보

Spike protein S1. Attaches the virion to the cell membrane by interacting with host receptor, initiating the infection. The major receptor is host ACE2 (PubMed : 32142651, PubMed : 32155444, PubMed : 33607086). When S2/S2' has been cleaved, binding to the receptor triggers direct fusion at the cell membrane (PubMed : 34561887). When S2/S2' has not been cleaved, binding to the receptor results in internalization of the virus by endocytosis using host TFRC and GRM2 and leading to fusion of the virion membrane with the host endosomal membrane (PubMed : 32075877, PubMed : 32221306, PubMed : 34903715, PubMed : 36779763). Alternatively, may use NRP1/NRP2 (PubMed : 33082294, PubMed : 33082293) and integrin as entry receptors (PubMed : 35150743). The use of NRP1/NRP2 receptors may explain the tropism of the virus in human olfactory epithelial cells, which express these molecules at high levels but ACE2 at low levels (PubMed : 33082293). Uses also ASGR1 as an alternative receptor in an ACE2-independent manner (PubMed : 34837059). The stalk domain of S contains three hinges, giving the head unexpected orientational freedom (PubMed : 32817270).. Spike protein S2. Precursor of the fusion protein processed in the biosynthesis of the S protein and the formation of virus particle. Mediates fusion of the virion and cellular membranes by functioning as a class I viral fusion protein. Contains two viral fusion peptides that are unmasked after cleavage. The S2/S2' cleavage occurs during virus entry at the cell membrane by host TMPRSS2 (PubMed : 32142651) or during endocytosis by host CSTL (PubMed : 32703818, PubMed : 34159616). In either case, this triggers an extensive and irreversible conformational change leading to fusion of the viral envelope with the cellular cytoplasmic membrane, releasing viral genomic RNA into the host cell cytoplasm (PubMed : 34561887). Under the current model, the protein has at least three conformational states : pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During fusion of the viral and target cell membranes, the coiled coil regions (heptad repeats) adopt a trimer-of-hairpins structure and position the fusion peptide in close proximity to the C-terminal region of the ectodomain. Formation of this structure appears to promote apposition and subsequent fusion of viral and target cell membranes.. Spike protein S2'. Subunit of the fusion protein that is processed upon entry into the host cell. Mediates fusion of the virion and cellular membranes by functioning as a class I viral fusion protein. Contains a viral fusion peptide that is unmasked after S2 cleavage. This cleavage can occur at the cell membrane by host TMPRSS2 or during endocytosis by host CSTL (PubMed : 32703818, PubMed : 34159616). In either case, this triggers an extensive and irreversible conformational change that leads to fusion of the viral envelope with the cellular cytoplasmic membrane, releasing viral genomic RNA into the host cell cytoplasm (PubMed : 34561887). Under the current model, the protein has at least three conformational states : pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During fusion of the viral and target cell membranes, the coiled coil regions (heptad repeats) adopt a trimer-of-hairpins structure and position the fusion peptide in close proximity to the C-terminal region of the ectodomain. Formation of this structure appears to promote apposition and subsequent fusion of viral and target cell membranes.
See full target information S

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com